regional_1_19_04

East

Egenera Inc. of Marlboro, Mass., raised $30 million from 23 accredited investors through a Series D convertible preferred stock round of financing. The manufacturer of computer hardware and software plans to use the proceeds from the offering for working capital. For more information, call Vern Brownell, executive officer, at 508-858-2600.

Invidi Technologies Corp. of New York raised $12 million from six accredited investors through a private offering of preferred stock. The software developer intends to use the proceeds from the offering for working capital. For more information, call David Downey, president, at 212-945-4247.

Diopsys Inc. of Metuchen, N.J., has filed to raise $2 million through a private offering of common stock with warrants. The exercise of warrants will bring in additional $1.4 million. John N. Seip & Co. Inc. is helping to place an issue for $200,000 in sales commissions and warrants for 10% of shares sold. The Web site developer intends to use the proceeds from the offering for salaries, fees, debt repayment and working capital. For more information, call Joseph Fontanetta, president, at 732-321-6566.

PTC Therapeutics Inc. of South Plainfield, N.J., has filed to raise $50 million through a private offering of Series E convertible preferred stock. At the time of its SEC filing, the company had already raised $35 million from 20 accredited investors. First Bermuda Securities helps to place an issue for $210,000 in findersí fees. A minimum investment of $100,000 is required on the placement. The biopharmaceutical company plans to use some proceeds from the offering for working capital. For more information, call Mark Boulding, vice president, at 908-222-7000 (ext. 103).

K12 Inc. of McLean, Va., raised $25 million from 48 accredited investors through a Series C preferred stock round of financing. The provider of education related services intends to use the proceeds from the offering for debt repayment and working capital. For more information, call Richard Rasmus, executive officer, at 703-748-4005.

Morphotek Inc. of Exton, Pa., has filed to raise $26 million through a Series C preferred stock round of financing. At the time of its SEC filing, the company had already raised $14.7 million from 22 accredited investors. The biotechnology company intends to use the proceeds from the offering for working capital. For more information, call Nicholas Nicolaides, president, at 610-423-6109.

Neuronyx Inc. of Malvern, Pa., raised $5.9 million from 35 accredited investors through a private placement of preferred stock. The biotechnology research company intends to use the proceeds from the offering for working capital. For more information, call Francis Michael Conway, CFO, at 610-240-4177.

Amperion Inc. of Andover, Mass., has filed to raise $2 million through a private offering of convertible debt with warrants. At the time of its SEC filing, the company had already raised $1.6 million from three accredited investors. A minimum investment of $100,000 is required on the placement. The provider of medium-voltage power line communication products and related services intends to use some proceeds from the offering for working capital. For more information, call Philip Hunt, president, at 978-824-2000.

BroadSoft Inc. of Gaithersburg, Md., has filed to raise $6.1 million through a Series C-1 convertible preferred stock round of financing. At the time of its SEC filing, the company had already raised $6 million from 19 accredited investors. The provider of broadband software plans to use the proceeds from the offering for working capital. For more information, call Phillip Salopek, CFO, at 240-364-5104.

Claragen Inc. of College Park, Md., has filed to raise $300,000 through a private offering of convertible notes and Series B convertible preferred stock warrants. At the time of its SEC filing, the company had already raised $135,000 from four accredited investors. The biopharmaceutical developer plans to use the proceeds from the offering for working capital. For more information, call Aprile Pilon, president, at 301-405-0742.

Back to top


South

Additech Inc. of Houston, Texas, has filed to raise $12.7 million through a private offering of units consisting of Series D convertible participating preferred stock with a five-year warrant. At the time of its SEC filing, the company had already raised $275,000 from eight accredited investors. Signature Capital Securities LLC of Northfield, Ill., is helping to place the issue for $632,500 in sales commissions. The developer of a patented system that dispenses fuel additives and displays advertising at the gasoline pump, plans to use the proceeds from the offering for salaries, fees, installation of machinery and equipment, debt repayment, and working capital. For more information, call Ralph Koehrer, president, at 203-775-9278.

Ceterus Networks Inc. of Allen, Texas, has filed to raise $15 million through a Series C preferred stock round of financing. At the time of its SEC filing, the company had already raised $9 million from six accredited investors. The developer of telecom transmissions and switching equipment, plans to use some proceeds from the offering for debt repayment and working capital. For more information, call David Stehlin, president, at 469-519-1100.

Netrake Corp. of Plano, Texas, raised $20 million from 13 accredited investors through a Series D convertible preferred stock round of financing. The telecom equipment developer intends to use the proceeds from the offering for working capital. For more information, call Bruce Hill, CEO, at 214-291-1000.

NexQL Corp. of Dallas raised $1 million from one accredited investor through a private placement of common stock. The provider of data management solutions intends to use the proceeds from the offering for working capital. For more information, call Elliott Brackett, CEO, at 972-715-6950.

Organ Transport Systems Inc. of Frisco, Texas, has filed to raise $5 million through a private placement of common stock. At the time of its SEC filing, the company had already raised $10,000 from one accredited investor. The developer of portable organ preservation and transport devices plans to use the proceeds from the offering for salaries and fees, purchase, rental or leasing and installation of machinery and equipment, debt repayment, product development and working capital. For more information, call Hyman White, president, at 214-618-7905.

Power Tube Inc. of Austin, Texas, has filed to raise $1.2 million through a private offering of Series A2 preferred stock with warrants. At the time of its SEC filing, the company had already raised $210,047 from eight accredited investors. Rutter and Wilbanks Corp. is helping to place the issue for $2,251 in findersí fees. The energy production technology developer plans to use proceeds from the offering for salaries and fees, research and development, and working capital. For more information, call Glenn Lovelace, CEO, at 512-858-9410.

Preferred Privacy Plus Inc. of Gretna, La., raised $100,000 from one accredited investor through a private placement of common stock. The provider of computer and Internet services intends to use the proceeds from the offering for working capital. For more information, call Pierre DeBuys, president, at 504-234-5052.

Inhibitex Inc. of Alpharetta, Ga., has filed to raise $20 million through a Series E preferred stock round of financing. At the time of its SEC filing, the company had already raised $18.5 million from nine accredited investors. The biopharmaceutical company intends to use the proceeds from the offering for working capital. For more information, call Russell Plumb, CFO, at 678-746-1100.

Back to top


Midwest

GRAFTcath Inc. of Coon Rapids, Minn., raised $5.8 million from six accredited investors through a Series B convertible preferred stock round of financing. The medical device company, which develops vascular access products, intends to use the proceeds from the offering for salaries and fees, construction or leasing of plant buildings and facilities, debt repayment, and working capital. For more information, call Curt Fox, CFO, at 763-792-1700.

MathStar Inc. of Minnetonka, Minn., has filed to raise $9 million through a private offering of common stock. At the time of its SEC filing, the company had already raised $2.8 million from 64 accredited investors. The minimum investment of $100,000 required on the placement can be waived. Feltl & Co. of Minneapolis is acting as an agent on the placement for $900,000 in sales commissions. The fabless semiconductor company intends to use the proceeds from the offering for working capital, manufacturing, sales and marketing. For more information, call Bryon Bequette, CFO, at 952-746-2200.

Back to top


West

Envivio Inc. of South San Francisco raised $3.9 million from 18 accredited investors through a private offering of convertible note and preferred stock warrant. The software developer plans to use the proceeds for working capital. For more information, call Albert Liong, CFO, at 650-875-3021.

Epic Technology Inc. of Campbell, Calif., raised $6.7 million from 14 accredited investors through a Series A preferred stock round of financing. The integrated circuit design developer intends to use the proceeds from the offering for working capital. For more information, call Dirk Brown, CEO, at 408-374-7288.

EyeCron Inc. of Oakland, Calif., raised $110,000 from six accredited investors through a convertible note and warrant round of financing. The provider of Internet digital media and communications services intends to use the proceeds from the offering for working capital. For more information, call Andres Davidovits, CEO, at 510-663-4815.

EVEO Inc. of San Francisco has filed to raise $800,000 through a Series A1 preferred stock round of financing. At the time of its SEC filing, the company had already raised $651,400 from 10 accredited investors. The company, engaged in electronic distribution of video content, intends to use the proceeds from the offering for working capital. For more information, call Olivier Zitoun, president, at 888-663-8001.

Data Domain Inc. of Palo Alto, Calif., raised $16.7 million from 28 accredited investors through a Series B preferred stock round of financing. The provider disk-based storage systems and services for data recovery intends to use the proceeds from the offering for working capital. For more information, call Frank Slootman, CEO, at 650-977-4127.

Five Prime Therapeutics Inc. of South San Francisco, Calif., raised $9.5 million from 11 accredited investors through a Series A preferred stock round of financing. The therapeutics discovery company intends to use the proceeds from the offering for working capital. For more information, call Lewis Williams, president, at 650-624-5942.

HydroPoint Data Systems Inc. of Petaluma, Calif., has filed to raise $4.5 million through a Series A preferred stock round of financing. At the time of its SEC filing, the company had already raised $3.1 million from five accredited investors. The company, which is developing water conservation technology systems, plans to use the proceeds from the offering for working capital. For more information, call Christopher Spain, CEO, at 707-969-9696.

Inovys Corp. of Pleasanton, Calif., has filed to raise $32.3 million through a Series C preferred stock round of financing. At the time of its SEC filing, the company had already raised $28.1 million from 27 accredited investors. The semiconductors company intends to use the proceeds from the offering for working capital. For more information, call Paul Sakamoto, executive officer, at 925-924-9110.

Oxygen Software Inc. of San Francisco has filed to raise $6 million through a Series C preferred stock round of financing. At the time of its SEC filing, the company had already raised $1.8 million from six accredited investors. The software developer, which provides wealth management services, plans to use the proceeds from the offering for working capital. For more information, call Robert Howe, executive officer, at 415-344-6100.

PhatNoise Inc. of Los Angeles has filed to raise $1.3 million through a private offering of convertible secured promissory notes. At the time of its SEC filing, the company had already raised $568,750 from five accredited investors. The software and hardware developer intends to use the proceeds from the offering for working capital. For more information, call Sharon Graves, president, at 310-954-3600.

Proteus Biomedical Inc. of Menlo Park, Calif., raised $5.3 million from 18 accredited investors through a Series B preferred stock round of financing. The biotechnological company intends to use the proceeds from the offering for working capital. For more information, call Andrew Thompson, executive officer, at 650-566-9100.

RaptorVision Inc. of San Mateo, Calif., raised $750,000 from six accredited investors through a Series A preferred stock round of financing. The network services provider intends to use the proceeds from the offering for working capital. For more information, call James Fowler, CEO, at 415-378-7416.

Riverbed Technology Inc. of San Francisco raised $10 million from 17 accredited investors through a Series B preferred stock round of financing. The developer of products for high performance network file access intends to use the proceeds from the offering for working capital. For more information, call Jerry Kennelly, CEO, at 415-247-8800.

Therapeutic Human Polyclonals Inc. of Mountain View, Calif., raised $5 million from two accredited investors through a Series B preferred stock round of financing. The biopharmaceutical company, which focuses on developing a platform to produce the next generation antibody therapy, intends to use the proceeds from the offering for working capital. For more information, call Wim C.A. van Schooten, CEO, at 650-625-8840.

Triesta Sciences Inc. of Menlo Park, Calif., raised $190,000 from seven accredited investors through a Series B preferred convertible stock round of financing. The life sciences company intends to use the proceeds from the offering for working capital. For more information, call Ganapati Gangadhara, executive officer, at 650-322-2797.

FusionWare Corp. of Friday Harbor, Wash., has filed to raise $10 million through a Series A preferred stock round of financing. At the time of its SEC filing, the company had already raised $4.8 million from nine accredited investors. The software developer intends to use the proceeds from the offering for working capital. For more information, call Alan Davis, president, at 206-914-4107.

Naverus Inc. of Renton, Wash., has filed to raise $1.9 million through a Series A preferred stock round of financing. At the time of its SEC filing, the company had already raised $1.4 million from 18 accredited investors. The software developer intends to use the proceeds from the offering for working capital. For more information, call Daniel Gerrity, executive officer, at 206-686-8352.

Exagen Diagnostics Inc. of Albuquerque, N.M., has filed to raise $5.4 million through a Series A convertible preferred stock round of financing. At the time of its SEC filing, the company had already raised $3.3 million from 10 accredited investors. A minimum investment of $26,145 is required on the placement. The molecular diagnostics development company intends to use the proceeds from the offering for working capital. For more information, call Waneta Tuttle, president, at 505-272-7966.

Back to top